Antibodies Lessen Effectiveness of Adalimumab / Humira
A new study proves what many suspected – that Rheumatoid Arthritis patients develop antibodies against adalimumab (Humira) which lessen the effectiveness of the drug. Previous studies have shown this to be true for other Biologic treatments as well.
Anti-adalimumab antibodies: another front in our battle against RA
Doctors in the Netherlands found 28% of patients developed antibodies...Continue reading 35 Comments »
Read more